☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Intas Pharmaceuticals
Intas Pharmaceuticals Entered into a Collaboration and License Agreement with mAbxience for Etanercept Biosimilar to Treat Autoimm...
December 20, 2023
Intas Pharmaceuticals Reports Real-World Study Results of Razumab (biosimilar, ranibizumab) for Polypoidal Choroidal Vasculopathy
April 15, 2023
Intas Pharmaceuticals Reports Retrospective Study Results of Razumab (biosimilar, ranibizumab) for the Treatment of Retinopathy of...
April 8, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.